Study Finds discordance between laboratory and CGM-estimated HbA1c
Hemoglobin A1C (HbA1c) is used as an index of average blood glucose measurement over a period of months and is a mainstay of blood glucose monitoring. However, in a recent study, researchers confirmed a discordance between laboratory and estimated (using the glucose management indicator [GMI]) glycated hemoglobin (HbA1c) from continuous glucose monitoring (CGM). The research has been published in Diabetes Technology & Therapeutics on March 22, 2021.
HbA1c metric is easy to measure and relatively inexpensive to obtain, and it predicts diabetes-related microvascular complications. However, HbA1c provides only an approximate measure of glucose control; it does not address short-term glycemic variability (GV) or hypoglycemic events. Continuous glucose monitoring (CGM) is a tool that helps clinicians and people with diabetes to overcome the limitations of HbA1c in diabetes management. Previous studies have shown a marked discordance between laboratory and estimated HbA1c (eA1C). This may cause errors in diabetes management. Jordan E. Perlman and his team conducted a study to further evaluate discordance between laboratory and CGM-estimated HbA1c (eA1C).
It was a retrospective review of patients with diabetes who use CGM. The researchers used the electronic medical record of the University of Washington to extract eligible encounters. They included a total of 641 separate office encounters of patients who use CGM and had HbA1c and sensor data fewer than 4 weeks apart. They calculated HbA1c-GMI discordance for each subject and assessed for any impact of comorbidities. They determined HbA1c-GMI discordance as the absolute difference between laboratory and eA1C.
Key findings of the study were:
- Among 641 encounters, the researchers identified that 91% had had type 1 diabetes and noted that most patients had diabetes for greater than 20 years.
- They observed that the mean duration of CGM wear was 24.5 ± 8 days.
- They found that only 11% of patients had HbA1c-GMI discordance <0.1%, but 50% and 22% had differences ≥0.5% and ≥1%.
- They noted that the incidence of discordance increased in patients with advanced chronic kidney disease (estimated glomerular filtration rate <60).
The authors concluded, "We found substantial discordance between laboratory and eA1C in a real-world setting. Clinicians need be aware that HbA1c may not as accurately reflect mean glucose as previously appreciated."
For further information:
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.